Helmer Ring‐Larsen

5.3k total citations · 1 hit paper
94 papers, 4.1k citations indexed

About

Helmer Ring‐Larsen is a scholar working on Hepatology, Epidemiology and Nephrology. According to data from OpenAlex, Helmer Ring‐Larsen has authored 94 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Hepatology, 52 papers in Epidemiology and 16 papers in Nephrology. Recurrent topics in Helmer Ring‐Larsen's work include Liver Disease and Transplantation (46 papers), Liver Disease Diagnosis and Treatment (46 papers) and Hepatitis C virus research (23 papers). Helmer Ring‐Larsen is often cited by papers focused on Liver Disease and Transplantation (46 papers), Liver Disease Diagnosis and Treatment (46 papers) and Hepatitis C virus research (23 papers). Helmer Ring‐Larsen collaborates with scholars based in Denmark, Sweden and Norway. Helmer Ring‐Larsen's co-authors include Jens H. Henriksen, Niels Juel Christensen, Alexander L. Gerbes, Paolo Geñtilini, Vicente Arroyo, Giacomo Laffi, Jürgen Schölmerich, F. J. Dudley, Pere Ginès and Telfer B. Reynolds and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Helmer Ring‐Larsen

90 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis†

1996 1.2k citations Alexander L. Gerbes, Helmer Ring‐Larsen et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Helmer Ring‐Larsen Denmark	31	3.2k	2.6k	1.4k	522	397	94	4.1k
Joan Gaya Spain	21	2.0k 0.6×	1.6k 0.6×	1.0k 0.7×	365 0.7×	138 0.3×	36	2.6k
Massimo Bolognesi Italy	36	2.9k 0.9×	2.8k 1.1×	1.7k 1.2×	189 0.4×	310 0.8×	145	4.3k
David Sacerdoti Italy	41	2.9k 0.9×	2.7k 1.0×	1.5k 1.1×	321 0.6×	423 1.1×	167	5.0k
Gilles Pomier–Layrargues Canada	37	3.7k 1.1×	3.4k 1.3×	1.8k 1.3×	110 0.2×	102 0.3×	92	4.8k
Fa‐Yauh Lee Taiwan	32	2.5k 0.8×	2.0k 0.8×	1.6k 1.2×	111 0.2×	101 0.3×	141	3.7k
Laurent Spahr Switzerland	40	3.1k 1.0×	3.4k 1.3×	1.7k 1.3×	94 0.2×	84 0.2×	154	5.7k
Bruno Schneeweiß Austria	33	647 0.2×	938 0.4×	780 0.6×	640 1.2×	140 0.4×	91	3.3k
Satheesh Nair United States	27	2.2k 0.7×	2.6k 1.0×	1.8k 1.3×	77 0.1×	201 0.5×	109	4.3k
Bent Adel Hansen Denmark	26	1.6k 0.5×	891 0.3×	860 0.6×	156 0.3×	45 0.1×	45	2.5k
S P Wilkinson United Kingdom	23	787 0.2×	502 0.2×	531 0.4×	291 0.6×	82 0.2×	52	1.8k

Countries citing papers authored by Helmer Ring‐Larsen

Since Specialization

Citations

This map shows the geographic impact of Helmer Ring‐Larsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helmer Ring‐Larsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helmer Ring‐Larsen more than expected).

Fields of papers citing papers by Helmer Ring‐Larsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helmer Ring‐Larsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helmer Ring‐Larsen. The network helps show where Helmer Ring‐Larsen may publish in the future.

Co-authorship network of co-authors of Helmer Ring‐Larsen

This figure shows the co-authorship network connecting the top 25 collaborators of Helmer Ring‐Larsen. A scholar is included among the top collaborators of Helmer Ring‐Larsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helmer Ring‐Larsen. Helmer Ring‐Larsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hansen, Hanne Boskov, et al.. (2014). Total plasma clearance versus urinary plasma clearance of ⁵¹ Cr-EDTA in patients with cirrhosis with and without fluid retention. Scandinavian Journal of Clinical and Laboratory Investigation. 75(1). 64–72. 5 indexed citations

Dalgård, Olav, Amir Moghaddam, Hans Verbaan, et al.. (2010). Il28B Genetic Variation And Treatment Response In Patients With Hcv Genotype 3 Infection. Hepatology. 52(4). 898–898. 4 indexed citations

Dalgård, Olav, Kristian Bjøro, Helmer Ring‐Larsen, & Hans Verbaan. (2010). In patients with HCV genotype 2 or 3 infection and RVR 14 weeks treatment is noninferior to 24 weeks. Pooled analysis of two Scandinavian trials. European Journal of Gastroenterology & Hepatology. 22(5). 552–556. 7 indexed citations

Dalgård, Olav, Hans Verbaan, Helmer Ring‐Larsen, & Kristian Bjøro. (2008). IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION AND RVR 14 WEEKS TREATMENT IS NON-INFERIOR TO 24 WEEKS. POOLED ANALYSIS OF TWO SCANDINAVIAN TRIALS. Hepatology. 48(4). 1875–1875. 2 indexed citations

Friis, Henrik, et al.. (2006). The effect of antioxidant supplementation on hepatitis C viral load, transaminases and oxidative status: a randomized trial among chronic hepatitis C virus-infected patients. European Journal of Gastroenterology & Hepatology. 18(9). 985–989. 35 indexed citations

Schmidt, Lars E. & Helmer Ring‐Larsen. (2006). Vasoconstrictor Therapy for Hepatorenal Syndrome in Liver Cirrhosis. Current Pharmaceutical Design. 12(35). 4637–4647. 10 indexed citations

Janssen, Harry L.A., Guido Gerken, Vicente Carréño, et al.. (1999). Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment. Hepatology. 30(1). 238–243. 115 indexed citations

Krogsgaard, Kim, Patrick Marcellin, C. Trépo, et al.. (1998). [Pretreatment with prednisolone enhances the effect of human lymphoblastoid interferon in chronic hepatitis B].. PubMed. 160(39). 5657–61. 2 indexed citations

Bjøro, Kristian, Henrik Krarup, H. Bell, et al.. (1995). Two Dose Regimens of Recombinant Interferon-Alpha-2b in Chronic Hepatitis C Virus Infection: Biochemistry, Hepatitis C Virus RNA, and Liver Histology as Response Indices. Scandinavian Journal of Gastroenterology. 30(11). 1119–1124. 10 indexed citations

10.

Krogsgaard, Kim, Niels Bindslev, Erik Christensen, et al.. (1994). The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. Journal of Hepatology. 21(4). 646–655. 70 indexed citations

11.

Henriksen, Jens H., Søren Møller, Flemming Bendtsen, et al.. (1994). Assessment of central blood volume in cirrhosis by radionuclide angiography. Hepatology. 4 indexed citations

12.

Lombard, Martin, Bernard Portmann, J. S. Neuberger, et al.. (1993). Cyclosporin a treatment in primary biliary cirrhosis: Results of a long-term placebo controlled trial. Gastroenterology. 104(2). 519–526. 101 indexed citations

13.

Henriksen, Jens H. & Helmer Ring‐Larsen. (1993). Renal effects of drugs used in the treatment of portal hypertension. Hepatology. 18(3). 688–695. 24 indexed citations

14.

Krogsgaard, Kim, P. Wantzin, L Mathiesen, & Helmer Ring‐Larsen. (1991). Chronic Evolution of Acute Hepatitis B: The Significance of Simultaneous Infections with Hepatitis C and D. Scandinavian Journal of Gastroenterology. 26(3). 275–280. 18 indexed citations

15.

Henriksen, Jens H., Helmer Ring‐Larsen, & Niels Juel Christensen. (1988). Kidney, lower limb and whole‐body uptake and release of catecholamines in alcoholic liver disease. Clinical Physiology. 8(3). 203–213. 14 indexed citations

16.

Henriksen, Jens H., Helmer Ring‐Larsen, & N. J. Christensen. (1987). Hepatic intestinal uptake and release of catecholamines in alcoholic cirrhosis. Evidence of enhanced hepatic intestinal sympathetic nervous activity.. Gut. 28(12). 1637–1642. 36 indexed citations

17.

Ring‐Larsen, Helmer, et al.. (1986). Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture.. BMJ. 292(6532). 1351–1353. 69 indexed citations

18.

Henriksen, Jens H., Helmer Ring‐Larsen, Inge‐Lis Kanstrup, & Niels Juel Christensen. (1984). Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis.. Gut. 25(10). 1034–1043. 163 indexed citations

19.

Engell, H. C., et al.. (1977). Splanchnic Blood Flow in Patients with Abdominal Angina Before and After Arterial Reconstruction A Proposal for a Diagnostic Test. Annals of Surgery. 186(2). 216–220. 40 indexed citations

20.

Ring‐Larsen, Helmer, Birger Hesse, & B. Stigsby. (1976). Effect of portal-systemic anastomosis on renal haemodynamics in cirrhosis.. Gut. 17(11). 856–860. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact